Home › Cases › New AF in Sepsis
Atrial Fibrillation
New AF in Sepsis
6 questions
Question 1 · Recognition
Correct answer: Treat the underlying sepsis — AF is likely secondary to systemic illness
Why
New AF in sepsis is usually secondary to the systemic insult (fever, hypoxia, catecholamine release). Treating the underlying sepsis will often cardiovert the AF spontaneously. Rate controlling if needed, but rhythm control is NOT the priority in acute illness.
Key point
New AF in sepsis: treat the sepsis first. The AF is usually secondary and will often resolve.
Question 2 · Rate control decision
Correct answer: Treat sepsis first; rate control only if still fast once stable; DC cardioversion if shock from AF
Why
Treat sepsis first; AF often settles. Still fast and causing problems once BP stable: bisoprolol 2.5 mg PO, after HF/BP review. Avoid IV beta-blockers if hypotensive. Digoxin is an option in low BP/HF (senior advice). Shock or pulmonary oedema from AF → synchronised DC cardioversion.
Key point
Treat sepsis first. Still fast once BP stable: bisoprolol 2.5 mg PO. Shock from AF: synchronised DC cardioversion.
Question 3 · Anticoagulation
Correct answer: Consider risk/benefit: in sepsis with thrombocytopaenia or bleeding risk, delay and reassess
Why
Anticoagulation in acute AF during sepsis: CHA₂DS₂-VASc guides long-term need, but acutely, consider sepsis-related thrombocytopaenia, DIC risk, and falls risk. The risk-benefit must be individually assessed. In most stable sepsis patients, anticoagulation should be initiated.
Key point
AF anticoagulation during sepsis: CHA₂DS₂-VASc guides need, but weigh bleeding risk during acute illness.
Question 4 · Cardioversion timing
Correct answer: Wait until sepsis resolved — allow AF to spontaneously cardiovert with treatment
Why
AF in the context of active infection often resolves spontaneously. Allow sepsis to fully resolve before considering elective cardioversion. If AF persists post-discharge, assess at outpatient follow-up. If duration uncertain/>48h, anticoagulate 3 weeks before cardioversion.
Key point
Let the sepsis resolve first. AF secondary to sepsis often self-terminates. Reassess at 6-week follow-up.
Question 5 · Discharge planning
Correct answer: Yes — CHA₂DS₂-VASc ≥2, anticoagulate regardless of rhythm
Why
Sinus rhythm does not remove the need for stroke-risk review: AF can recur silently. Under NICE, CHA₂DS₂-VASc ≥2 in either sex → offer anticoagulation after bleeding-risk assessment; consider it in men with score 1. Female sex alone is not an indication. For this sepsis-associated episode, confirm the documented long-term plan as acute bleeding risk resolves.
Key point
Anticoagulation is about CHA₂DS₂-VASc score, not rhythm. Sinus rhythm doesn't stop the need.
Question 6 · Follow-up
Correct answer: Cardiology or arrhythmia clinic: repeat ECG, ongoing anticoagulation review, rate control optimisation, consideration of rhythm control strategy
Why
New AF requires structured follow-up: outpatient cardiology/arrhythmia clinic for ongoing management. Rhythm control strategy (cardioversion, ablation) if AF symptomatic long-term. Annual review of anticoagulation and rate/rhythm status.
Key point
New AF: cardiology/arrhythmia outpatient follow-up. Anticoagulation, rate/rhythm strategy to be reviewed.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.